Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A comprehensive analysis of different types of databases reveals that CDH1 mRNA and E-cadherin protein are not downregulated in most carcinoma tissues and carcinoma cell lines

Fig. 5

Immunohistochemistry staining reveals that E-cad protein is not downregulated in most carcinoma tissues. Immunohistochemistry staining of E-cad in breast carcinoma (A), head/neck carcinoma (B), pancreatic carcinoma (C), and kidney carcinoma (D), and their corresponding normal tissues. E, Most carcinoma tissues exhibit medium to high intensity of E-cad staining except for kidney carcinoma, which exhibits little or no E-cad staining in most of the tumor tissues

Back to article page